Does adipose tissue-derived stem cell therapy improve graft quality in freshly grafted ovaries?

24Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: A major concern in ovarian transplants is substantial follicle loss during the initial period of hypoxia. Adipose tissue-derived stem cells (ASCs) have been employed to improve angiogenesis when injected into ischemic tissue. This study evaluated the safety and efficacy of adipose tissue-derived stem cells (ASCs) therapy in the freshly grafted ovaries 30days after injection. Methods: Rat ASCs (rASCs) obtained from transgenic rats expressing green fluorescent protein (GFP)-(5×10 4 cells/ovary) were injected in topic (intact) or freshly grafted ovaries of 30 twelve-week-old adult female Wistar rats. The whole ovary was grafted in the retroperitoneum without vascular anastomosis, immediately after oophorectomy. Vaginal smears were performed daily to assess the resumption of the estrous cycle. Estradiol levels, grafts morphology and follicular viability and density were analyzed. Immunohistochemistry assays were conducted to identify and quantify rASC-GFP +, VEGF tissue expression, apoptosis (cleaved caspase-3 and TUNEL), and cell proliferation (Ki-67). Quantitative gene expression (qPCR) for VEGF-A, Bcl2, EGF and TGF-β1 was evaluated using RT-PCR and a double labeling immunofluorescence assay for GFP and Von Willebrand Factor (VWF) was performed. Results: Grafted ovaries treated with rASC-GFP + exhibited earlier resumption of the estrous phase (p<0.05), increased VEGF-A expression (11-fold in grafted ovaries and 5-fold in topic ovaries vs. control) and an increased number of blood vessels (p<0.05) in ovarian tissue without leading to apoptosis or cellular proliferation (p>0.05). Estradiol levels were similar among groups (p>0.05). rASC-GFP + were observed in similar quantities in the topic and grafted ovaries (p>0.05), and double-labeling for GFP and vWF was observed in both injected groups. Conclusion: rASC therapy in autologous freshly ovarian grafts could be feasible and safe, induces earlier resumption of the estrous phase and enhances blood vessels in rats. This pilot study may be useful in the future for new researches on frozen-thawed ovarian tissue.

Cite

CITATION STYLE

APA

Damous, L. L., Nakamuta, J. S., Saturi de Carvalho, A. E. T., Carvalho, K. C., Soares-Jr, J. M., Simões, M. de J., … Baracat, E. C. (2015). Does adipose tissue-derived stem cell therapy improve graft quality in freshly grafted ovaries? Reproductive Biology and Endocrinology, 13(1). https://doi.org/10.1186/s12958-015-0104-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free